Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Hematology

Managing Symptoms and Recognizing Warning Signs

At a Glance

Myelofibrosis can cause an enlarged spleen, early fullness, fatigue, night sweats, bone pain, weight loss, and low-blood-count symptoms. Seek emergency help for major bleeding, clot symptoms, or sudden severe abdominal pain, and contact your care team promptly for fever or sudden changes.

Living with myelofibrosis (MF) means managing a wide range of symptoms that can affect your daily life. These symptoms occur because your bone marrow is no longer able to produce blood cells efficiently, and your body is trying to compensate for that loss [1][2]. Understanding which symptoms are “normal” for your condition and which ones require immediate medical attention is a vital part of managing your health.

Why the Spleen Enlarges

The most common physical sign of myelofibrosis is an enlarged spleen, known as splenomegaly [3]. Because the scarred bone marrow cannot make enough blood cells, your body moves this “blood factory” to other organs, primarily the spleen and sometimes the liver [4]. This process is called extramedullary hematopoiesis [5].

As the spleen grows to accommodate this new job, it can cause several symptoms:

  • Abdominal Discomfort: You may feel a dull ache, heaviness, or pressure under your ribs on the left side [6].
  • Early Satiety: Because the spleen sits right next to your stomach, an enlarged spleen can press against it. This makes you feel full after eating only a few bites of food [7].
  • Splenic Infarction: In some cases, a part of the spleen may lose its blood supply, causing sharp, severe pain in the upper left abdomen [8].

Constitutional Symptoms

Many patients experience constitutional symptoms, which are whole-body effects caused by high levels of inflammation [9]. These include:

  • Extreme Fatigue: This is a very common symptom, reported by a large majority of patients [10]. It is often more severe than normal tiredness and is not always relieved by rest.
  • Night Sweats and Low-Grade Fevers: These can be drenching and may require you to change your clothes or sheets during the night [10].
  • Bone Pain: You may feel a deep, aching pain in your bones or joints [10].
  • Unintentional Weight Loss: This is often linked to the high energy your body uses to fight inflammation and the “early fullness” caused by the spleen [7].

Symptoms of Low Blood Counts

As the disease progresses, the bone marrow produces fewer healthy blood cells, leading to cytopenias (low blood counts) [1]:

  • Anemia (Low Red Blood Cells): This causes weakness, shortness of breath, and a pale appearance [9].
  • Thrombocytopenia (Low Platelets): Platelets help your blood clot. If they are too low, you may notice easy bruising, small red spots on the skin (petechiae), or frequent nosebleeds [9][11].

Red Flags: When to Seek Urgent Care

While many MF symptoms are chronic and manageable, some situations are medical emergencies. It is important to distinguish between your “typical” daily symptoms and these red flags.

🚨 Call Emergency Services (911) Immediately For:

Myelofibrosis can cause high pressure in the veins leading to the liver (portal hypertension) or severe blood clots (thrombosis) [12][13].

  • Major Bleeding: Vomiting blood (may look like coffee grounds) or passing black, tarry stools. This can indicate bleeding from varices (enlarged veins in the esophagus or stomach) [14][15].
  • Clotting Emergencies: Sudden one-sided weakness, difficulty speaking, severe new chest pain, severe shortness of breath, fainting, or a suddenly swollen, painful leg.
  • Severe Abdominal Crisis: Sudden, severe, or rapidly worsening abdominal pain or a rapid increase in abdominal swelling. This can signify a splanchnic vein thrombosis or a splenic emergency [16][17].

⚠️ Contact Your Care Team Same-Day For:

Because your immune system may be weakened by the disease or its treatments, infections can become dangerous quickly [18].

  • Signs of Infection: A fever that reaches your doctor’s specific threshold (often over 100.4°F or 38°C), chills, or any signs of severe infection [19].
  • Signs Requiring Prompt Evaluation: An abrupt, dramatic decline in your health, such as severe new exhaustion, a rapidly enlarging spleen over just a few days, or a sudden change in your blood counts. While rarely a sign of disease transformation, this requires medical assessment to rule out bleeding or infarction [20][21].

Note: Typical daily fatigue or a consistent feeling of mild abdominal fullness are part of the chronic nature of MF and are generally not emergencies. However, any new or sudden change in these symptoms warrants a call to your care team.

Common questions in this guide

What symptoms are common with myelofibrosis?
Common symptoms include fatigue, night sweats, low-grade fevers, bone or joint pain, and unintentional weight loss. An enlarged spleen may cause pressure or aching under the left ribs and early fullness after only a small amount of food. Low blood counts can also cause weakness, shortness of breath, bruising, pinpoint red skin spots, or nosebleeds.
Which myelofibrosis symptoms require emergency help?
Call emergency services for vomiting blood, black or tarry stools, sudden one-sided weakness, trouble speaking, severe new chest pain, severe shortness of breath, fainting, or a suddenly swollen and painful leg. Sudden severe or rapidly worsening abdominal pain or swelling also needs immediate assessment because it may signal serious bleeding, a blood clot, or a spleen emergency.
When should I call my care team about a fever?
Use the fever threshold provided by your care team; it is often 100.4°F (38°C) or higher. Call the same day for a fever, chills, or other signs of infection because myelofibrosis or its treatments can weaken immune defenses.
Why do I feel full after eating only a little with myelofibrosis?
Myelofibrosis can enlarge the spleen because blood-cell production shifts outside the scarred bone marrow. The spleen sits next to the stomach, so its increased size can press on the stomach and cause early fullness, left-sided heaviness, or discomfort.
How can I tell if my myelofibrosis symptoms are getting worse?
Keep a record of your usual fatigue, abdominal fullness, night sweats, pain, temperature, and other symptoms. Contact your care team if symptoms change suddenly, become much more severe, the spleen seems to enlarge quickly, or you notice a major change in blood counts.
What do low blood counts mean for bleeding or breathing symptoms?
A low red-blood-cell count can cause weakness, shortness of breath, and paleness. A low platelet count can lead to easy bruising, pinpoint red spots, or nosebleeds, so ask your care team what your results mean and which bleeding or clotting signs require urgent help.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on myelofibrosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my current spleen size or any of my symptoms suggest that portal hypertension is developing?
  2. 2.What should I consider a 'baseline' level for my fatigue and abdominal fullness, and at what point should I call the office between appointments?
  3. 3.Are my recent blood counts showing any increase in 'blasts' (immature white blood cells)?
  4. 4.Based on my platelet count, what are my risks for bleeding or clotting, and what exact signs should I look for?
  5. 5.How do my constitutional symptoms (like night sweats or bone pain) affect my overall risk score and treatment plan?

References

References (21)
  1. 1

    Primary Myelofibrosis (PMF)-The German ONKOPEDIA Guideline 2025.

    Griesshammer M, Al-Ali HK, Baerlocher GM, et al.

    International journal of cancer 2026; (159(7)):1642-1662 doi:10.1002/ijc.70596.

    PMID: 42324204
  2. 2

    Myelofibrosis biology and contemporary management.

    Gangat N, Tefferi A

    British journal of haematology 2020; (191(2)):152-170 doi:10.1111/bjh.16576.

    PMID: 32196650
  3. 3

    Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis.

    Guglielmelli P, Pacilli A, Rotunno G, et al.

    Blood 2017; (129(24)):3227-3236 doi:10.1182/blood-2017-01-761999.

    PMID: 28351937
  4. 4

    CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis.

    Mirabile M, Tombari C, Neroni A, et al.

    Journal of cellular and molecular medicine 2025; (29(14)):e70720 doi:10.1111/jcmm.70720.

    PMID: 40690545
  5. 5

    Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis.

    Song MK, Park BB, Uhm JE

    International journal of molecular sciences 2018; (19(3)) doi:10.3390/ijms19030898.

    PMID: 29562644
  6. 6

    Modern management of splenomegaly in patients with myelofibrosis.

    Tremblay D, Schwartz M, Bakst R, et al.

    Annals of hematology 2020; (99(7)):1441-1451 doi:10.1007/s00277-020-04069-4.

    PMID: 32417942
  7. 7

    Spatial-transcriptomic profiling: a new lens for understanding myelofibrosis pathophysiology.

    Peroni E, Calistri E, Amato R, et al.

    Cell communication and signaling : CCS 2024; (22(1)):510 doi:10.1186/s12964-024-01877-3.

    PMID: 39434124
  8. 8

    Liver infarct masquerading as intrahepatic cholangiocarcinoma.

    Fariduddin MM, Syed W, Birjees A, Naqvi MR

    Proceedings (Baylor University. Medical Center) 2021; (34(6)):693-695 doi:10.1080/08998280.2021.1930968.

    PMID: 34732990
  9. 9

    Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis.

    Pastor-Galán I, Hernández-Boluda JC, Correa JG, et al.

    Medicina clinica 2020; (155(4)):152-158 doi:10.1016/j.medcli.2019.11.007.

    PMID: 31980217
  10. 10

    [The assessment of symptomatic burden among Ph/BCR- ABL negative myeloproliferative neoplasm patients].

    Xu J, Xu Z, Wang J, et al.

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2016; (37(1)):26-9 doi:10.3760/cma.j.issn.0253-2727.2016.01.005.

    PMID: 26876249
  11. 11

    Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis.

    Masarova L, Alhuraiji A, Bose P, et al.

    European journal of haematology 2018; (100(3)):257-263 doi:10.1111/ejh.13005.

    PMID: 29226426
  12. 12

    Myelofibrosis-associated extramedullary hematopoiesis: Insights into hepatic, pulmonary, and thrombotic complications.

    Amanam I, Otoukesh S, Pullarkat V, et al.

    Blood reviews 2026; (75()):101355 doi:10.1016/j.blre.2025.101355.

    PMID: 41344966
  13. 13

    Myelofibrosis and Portal Hypertension: The Case for Primary Variceal Screening.

    Sherman MS, Samore WR, Pratt DS

    ACG case reports journal 2020; (7(2)):e00333 doi:10.14309/crj.0000000000000333.

    PMID: 32440527
  14. 14

    Acute upper gastrointestinal bleeding due to portal hypertension in a patient with primary myelofibrosis: A case report.

    Chen Y, Kong BB, Yin H, et al.

    World journal of clinical cases 2024; (12(15)):2621-2626 doi:10.12998/wjcc.v12.i15.2621.

    PMID: 38817215
  15. 15

    Massive upper gastrointestinal bleeding due to splenoportal axis thrombosis in a patient with a tested JAK2 mutation: A case report and review literature.

    Macías I

    International journal of surgery case reports 2016; (28()):93-96 doi:10.1016/j.ijscr.2016.08.013.

    PMID: 27693837
  16. 16

    Primary Myelofibrosis in the Prefibrotic Stage Presenting as Portal, Splenic, and Superior Mesenteric Vein Thrombosis: A Case Report and Review of the Literature.

    Dias E, Liberal R, Costa-Moreira P, et al.

    GE Portuguese journal of gastroenterology 2022; (29(2)):125-131 doi:10.1159/000514658.

    PMID: 35497670
  17. 17

    Spontaneous bacterial peritonitis in non-cirrhotic portal hypertension secondary to primary myelofibrosis: A rare case report.

    Pradana FR, Nuramalia LS, Maimunah U

    iLIVER 2026; (5(2)):100239 doi:10.1016/j.iliver.2026.100239.

    PMID: 42179654
  18. 18

    20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long-lived patients.

    Penna D, Lasho TL, Finke CM, et al.

    American journal of hematology 2019; (94(3)):286-290 doi:10.1002/ajh.25351.

    PMID: 30516867
  19. 19

    SOHO State of the Art Updates and Next Questions | Updates on Myelofibrosis With Cytopenia.

    Khan MA, Palmer J

    Clinical lymphoma, myeloma & leukemia 2025; (25(5)):293-303 doi:10.1016/j.clml.2024.09.002.

    PMID: 39516086
  20. 20

    SOHO State of the Art Updates and Next Questions | Choosing and Properly Using a JAK Inhibitor in Myelofibrosis.

    Hochman MJ, Vale CA, Hunter AM

    Clinical lymphoma, myeloma & leukemia 2025; (25(4)):226-239 doi:10.1016/j.clml.2024.09.001.

    PMID: 39358153
  21. 21

    Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis.

    Masarova L, Bose P, Daver N, et al.

    Leukemia research 2017; (59()):110-116 doi:10.1016/j.leukres.2017.06.001.

    PMID: 28601551

This page about myelofibrosis symptoms and warning signs is for informational purposes only and does not constitute medical advice. Contact your care team for personalized guidance, and seek emergency help for severe or sudden symptoms.